Spectranetics develops, manufactures, markets and distributes medical devices used in minimally invasive procedures within the cardiovascular system. Spectranetic's clinical solutions are trusted in over 65 countries and are used to treat arterial blockages in the heart and legs and to remove pacemaker and defibrillator leads. The company was founded on and remains dedicated to product innovation, continually investigating new ways to meet the demands of the most challenging minimally invasive cardiac lead removal and vascular intervention procedures.
